Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: Possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer
Kimberly R. Kalli, Sarah V. Bradley, Susanne Fuchshuber, Cheryl A. Conover
Dive into the research topics of 'Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: Possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer'. Together they form a unique fingerprint.